TipRanks
Go Ultimate55% OFF

Sukumar Nagendran Insider Profile

18 Followers

Sukumar Nagendran, President and Head of R&D, Director at Taysha Gene Therapies, holds 936.41K shares in Taysha Gene Therapies (Ticker: TSHA), holds 34.26K shares in Solid Biosciences (Ticker: SLDB), holds 0.00 shares in AveXis Inc (Ticker: AVXS).

Sukumar Nagendran's Trading History

TSHA
Taysha Gene Therapies
Jul 10, 2026President and Head of R&D, DirectorUninformative Sell1.25M$3.87M
SLDB
Solid Biosciences
Jul 29, 2019DirectorUninformative Buy150.00K$212.40K
AVXS
AveXis Inc
May 15, 2018―Uninformative Sell―$0.00

You May Also Like

Sukumar Nagendran insider profile FAQ

What is the percentage of profitable transactions made by Sukumar Nagendran?
The percentage of profitable transactions made by Sukumar Nagendran is 60%.
What is the average return per transaction made by Sukumar Nagendran?
The average return per transaction made by Sukumar Nagendran is 34.70%.
What stocks does Sukumar Nagendran hold?
Sukumar Nagendran holds: TSHA, AVXS, SLDB stocks.
What was Sukumar Nagendran’s latest transaction?
Sukumar Nagendran’s latest transaction was an Uninformative Sell of $1.25M.
What was Sukumar Nagendran's most profitable transaction?
Sukumar Nagendran’s most profitable transaction was an Informative Buy of TSHA stock on May 18, 2023. The return on the trade was 341.40%.
What is Sukumar Nagendran's role in Taysha Gene Therapies?
Sukumar Nagendran's role in Taysha Gene Therapies is President and Head of R&D, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.